Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Aptevo Therapeutics (APVO) Return on Invested Capital (2016 - 2019)

Aptevo Therapeutics' Return on Invested Capital history spans 3 years, with the latest figure at 1.59% for Q3 2019.

  • For Q3 2019, Return on Invested Capital changed N/A year-over-year to 1.59%; the TTM value through Sep 2019 reached 1.59%, changed N/A, while the annual FY2017 figure was 0.61%, 782719.0% down from the prior year.
  • Return on Invested Capital for Q3 2019 was 1.59% at Aptevo Therapeutics, down from 0.47% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.19% in Q2 2016 and bottomed at 2.69% in Q1 2017.
  • The 3-year median for Return on Invested Capital is 1.14% (2016), against an average of 1.39%.
  • The largest YoY upside for Return on Invested Capital was 219bps in 2017 against a maximum downside of -249bps in 2017.
  • A 3-year view of Return on Invested Capital shows it stood at 2.67% in 2016, then surged by 82bps to 0.47% in 2017, then plummeted by -236bps to 1.59% in 2019.
  • Per Business Quant, the three most recent readings for APVO's Return on Invested Capital are 1.59% (Q3 2019), 0.47% (Q4 2017), and 0.76% (Q3 2017).